应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ITOS iTeos Therapeutics
盘后交易 04-30 16:06:36 EDT
7.25
+0.40
+5.84%
盘后
7.25
+0.00
0.00%
16:00 EDT
最高
7.30
最低
6.61
成交量
81.66万
今开
6.79
昨收
6.85
日振幅
10.07%
总市值
2.77亿
流通市值
2.12亿
总股本
3,827万
成交额
581.53万
换手率
2.80%
流通股本
2,921万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Iteos Therapeutics, Inc.盘中异动 股价大涨5.42%
市场透视 · 04-15
Iteos Therapeutics, Inc.盘中异动 股价大涨5.42%
Iteos Therapeutics, Inc.2024财年实现净利润-1.34亿美元,同比减少18.58%
市场透视 · 03-09
Iteos Therapeutics, Inc.2024财年实现净利润-1.34亿美元,同比减少18.58%
小摩:维持ITeos Therapeutics(ITOS.US)评级,由增持调整至增持评级, 目标价由22.00美元调整至15.00美元。
金融界 · 03-06
小摩:维持ITeos Therapeutics(ITOS.US)评级,由增持调整至增持评级, 目标价由22.00美元调整至15.00美元。
Iteos Therapeutics, Inc.盘中异动 股价大涨5.04%报7.20美元
市场透视 · 03-05
Iteos Therapeutics, Inc.盘中异动 股价大涨5.04%报7.20美元
ITeos Therapeutics 2024年第4季度 GAAP每股收益$(1.01) 超过$(1.06) 预期,2024年12月31日现金和投资余额为6.55亿美元,预计可支撑至2027年
财报速递 · 03-05
ITeos Therapeutics 2024年第4季度 GAAP每股收益$(1.01) 超过$(1.06) 预期,2024年12月31日现金和投资余额为6.55亿美元,预计可支撑至2027年
Iteos Therapeutics, Inc.盘中异动 临近午盘快速拉升5.00%
市场透视 · 02-28
Iteos Therapeutics, Inc.盘中异动 临近午盘快速拉升5.00%
Iteos Therapeutics, Inc.盘中异动 下午盘股价大涨5.07%报7.87美元
市场透视 · 01-30
Iteos Therapeutics, Inc.盘中异动 下午盘股价大涨5.07%报7.87美元
Iteos Therapeutics, Inc.盘中异动 早盘股价大涨5.61%报8.09美元
市场透视 · 01-15
Iteos Therapeutics, Inc.盘中异动 早盘股价大涨5.61%报8.09美元
Iteos Therapeutics, Inc.盘中异动 早盘快速拉升5.21%报7.67美元
市场透视 · 2024-12-31
Iteos Therapeutics, Inc.盘中异动 早盘快速拉升5.21%报7.67美元
Iteos Therapeutics, Inc.2024财年第三财季实现净利润-45.36百万美元,同比减少40.69%
市场透视 · 2024-11-14
Iteos Therapeutics, Inc.2024财年第三财季实现净利润-45.36百万美元,同比减少40.69%
Iteos Therapeutics, Inc.盘中异动 快速上涨5.33%
市场透视 · 2024-11-01
Iteos Therapeutics, Inc.盘中异动 快速上涨5.33%
Iteos Therapeutics, Inc.盘中异动 股价大涨5.12%报9.04美元
市场透视 · 2024-10-25
Iteos Therapeutics, Inc.盘中异动 股价大涨5.12%报9.04美元
Iteos Therapeutics, Inc.盘中异动 急速下跌5.09%报8.95美元
市场透视 · 2024-10-21
Iteos Therapeutics, Inc.盘中异动 急速下跌5.09%报8.95美元
Iteos Therapeutics, Inc.盘中异动 临近午盘快速下挫5.33%报10.04美元
市场透视 · 2024-09-24
Iteos Therapeutics, Inc.盘中异动 临近午盘快速下挫5.33%报10.04美元
加载更多
公司概况
公司名称:
iTeos Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
iTeos Therapeutics, Inc.根据特拉华州法律于2019年10月4日成立。该公司是临床阶段的生物制药公司,率先发现和开发了面向患者的新一代高度分化的免疫肿瘤疗法。该公司利用他们对肿瘤微环境和免疫抑制途径的深刻理解来设计新的候选药物,目的是提高肿瘤治疗的临床疗效。
发行价格:
--
{"stockData":{"symbol":"ITOS","market":"US","secType":"STK","nameCN":"iTeos Therapeutics","latestPrice":7.25,"timestamp":1746043200000,"preClose":6.85,"halted":0,"volume":816551,"hourTrading":{"tag":"盘后","latestPrice":7.25,"preClose":7.25,"latestTime":"16:00 EDT","volume":2358,"amount":17095.5,"timestamp":1746043240627},"delay":0,"floatShares":29208260,"shares":38273795,"eps":-3.090709,"marketStatus":"盘后交易","change":0.4,"latestTime":"04-30 16:06:36 EDT","open":6.79,"high":7.3,"low":6.61,"amount":5815305.889461,"amplitude":0.10073,"askPrice":18.63,"askSize":13,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.090709,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1746057600000},"marketStatusCode":4,"adr":0,"listingDate":1595563200000,"exchange":"NASDAQ","adjPreClose":6.85,"postHourTrading":{"tag":"盘后","latestPrice":7.25,"preClose":7.25,"latestTime":"16:00 EDT","volume":2358,"amount":17095.5,"timestamp":1746043240627},"volumeRatio":1.880612,"impliedVol":1.6597,"impliedVolPercentile":0.948},"requestUrl":"/m/hq/s/ITOS","defaultTab":"news","newsList":[{"id":"2527486784","title":"Iteos Therapeutics, Inc.盘中异动 股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527486784","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527486784?lang=zh_cn&edition=full","pubTime":"2025-04-15 21:45","pubTimestamp":1744724703,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日21时45分,Iteos Therapeutics, Inc.股票出现异动,股价大幅上涨5.42%。截至发稿,该股报5.83美元/股,成交量1.4361万股,换手率0.04%,振幅4.88%。Iteos Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.10%。其相关个股中,Mural Oncology Plc、Verve Therapeutics, Inc.、Prokidney Corp.涨幅较大,Mural Oncology Plc、Metavia Inc.、Plus Therapeutics, Inc.较为活跃,换手率分别为530.35%、213.66%、84.67%,振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Mural Oncology Plc、Nextcure, Inc.,振幅分别为80.08%、66.02%、38.78%。Iteos Therapeutics, Inc.公司简介:ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504152145039738a8fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504152145039738a8fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ITOS","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2518289739","title":"Iteos Therapeutics, Inc.2024财年实现净利润-1.34亿美元,同比减少18.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518289739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518289739?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:00","pubTimestamp":1741536046,"startTime":"0","endTime":"0","summary":"3月10日,Iteos Therapeutics, Inc.公布财报,公告显示公司2024财年净利润为-1.34亿美元,同比减少18.58%;其中营业收入为35.00百万美元,同比增加177.78%,每股基本收益为-3.32美元。从资产负债表来看,Iteos Therapeutics, Inc.总负债96.68百万美元,其中短期债务1.34百万美元,资产负债比为0.08,流动比率为0.13。机构评级:截至2025年3月10日,当前有5家机构对Iteos Therapeutics, Inc.目标价做出预测,其中目标均价为18.80美元,其中最低目标价为15.00美元,最高目标价为25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000113a2689809&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000113a2689809&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ITOS","LENZ"],"gpt_icon":0},{"id":"2517194167","title":"小摩:维持ITeos Therapeutics(ITOS.US)评级,由增持调整至增持评级, 目标价由22.00美元调整至15.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517194167","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517194167?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:25","pubTimestamp":1741278312,"startTime":"0","endTime":"0","summary":"小摩:维持ITeos Therapeutics(ITOS.US)评级,由增持调整至增持评级, 目标价由22.00美元调整至15.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07002548577309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ITOS","LENZ"],"gpt_icon":0},{"id":"2517940504","title":"Iteos Therapeutics, Inc.盘中异动 股价大涨5.04%报7.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517940504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517940504?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:06","pubTimestamp":1741198006,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时06分,Iteos Therapeutics, Inc.股票出现异动,股价急速拉升5.04%。截至发稿,该股报7.20美元/股,成交量17.06万股,换手率0.47%,振幅5.55%。Iteos Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.46%。其相关个股中,Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nutriband Inc C/Wts 涨幅较大,Silexion Therapeutics Corp、Tc Biopharm Plc、Bioxcel Therapeutics, Inc.较为活跃,换手率分别为946.28%、305.29%、299.42%,振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.,振幅分别为82.59%、54.27%、47.22%。Iteos Therapeutics, Inc.公司简介:ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306020646989d753b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306020646989d753b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ITOS"],"gpt_icon":0},{"id":"1153201753","title":"ITeos Therapeutics 2024年第4季度 GAAP每股收益$(1.01) 超过$(1.06) 预期,2024年12月31日现金和投资余额为6.55亿美元,预计可支撑至2027年","url":"https://stock-news.laohu8.com/highlight/detail?id=1153201753","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153201753?lang=zh_cn&edition=full","pubTime":"2025-03-05 20:14","pubTimestamp":1741176886,"startTime":"0","endTime":"0","summary":"ITeos Therapeutics 报告其季度亏损为每股$,这比分析师普遍预期的$高出4.72%。与去年同期每股亏损$相比,这一数字下降了18.82%。以上内容来自Benzinga Earnings专栏,原文如下:ITeos $Therapeutics$ reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 4.72 percent. This is a 18.82 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ITOS","LENZ"],"gpt_icon":0},{"id":"2516371110","title":"Iteos Therapeutics, Inc.盘中异动 临近午盘快速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516371110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516371110?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:33","pubTimestamp":1740760400,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时33分,Iteos Therapeutics, Inc.股票出现异动,股价大幅拉升5.00%。截至发稿,该股报7.35美元/股,成交量26.746万股,换手率0.73%,振幅5.57%。Iteos Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.19%。其相关个股中,Bioxcel Therapeutics, Inc.、Camp4 Therapeutics Corporation、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大,Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为2886.07%、489.39%、363.32%,振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ,振幅分别为57.80%、46.60%、43.95%。Iteos Therapeutics, Inc.公司简介:ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301003320abe10752&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301003320abe10752&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ITOS"],"gpt_icon":0},{"id":"2507180674","title":"Iteos Therapeutics, Inc.盘中异动 下午盘股价大涨5.07%报7.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507180674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507180674?lang=zh_cn&edition=full","pubTime":"2025-01-31 02:59","pubTimestamp":1738263592,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日02时59分,Iteos Therapeutics, Inc.股票出现波动,股价快速拉升5.07%。截至发稿,该股报7.87美元/股,成交量8.4172万股,换手率0.23%,振幅5.87%。Iteos Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.41%。其相关个股中,Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 涨幅较大,Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃,换手率分别为1780.26%、295.39%、237.78%,振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Immatics N V C/Wts 01/07/2025 、Alterity Therapeutics Limited,振幅分别为65.98%、63.82%、61.86%。Iteos Therapeutics, Inc.公司简介:ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131025953abbd79b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131025953abbd79b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ITOS","LENZ"],"gpt_icon":0},{"id":"2503528642","title":"Iteos Therapeutics, Inc.盘中异动 早盘股价大涨5.61%报8.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503528642","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503528642?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951533,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分,Iteos Therapeutics, Inc.股票出现异动,股价大幅拉升5.61%。截至发稿,该股报8.09美元/股,成交量9647股,换手率0.03%,振幅2.09%。Iteos Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.77%。其相关个股中,Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Generation Bio Co.涨幅较大,Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃,换手率分别为185.03%、52.76%、35.39%,振幅较大的相关个股有Onconetix, Inc.、Klotho Neurosciences, Inc.、Vincerx Pharma, Inc.,振幅分别为12.28%、12.00%、10.72%。Iteos Therapeutics, Inc.公司简介:ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232149604b412&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232149604b412&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ITOS"],"gpt_icon":0},{"id":"2495611764","title":"Iteos Therapeutics, Inc.盘中异动 早盘快速拉升5.21%报7.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495611764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495611764?lang=zh_cn&edition=full","pubTime":"2024-12-31 23:36","pubTimestamp":1735659392,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日23时36分,Iteos Therapeutics, Inc.股票出现波动,股价大幅拉升5.21%。截至发稿,该股报7.67美元/股,成交量59.1506万股,换手率1.62%,振幅5.90%。Iteos Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.40%。其相关个股中,Onconetix, Inc.、知临集团、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Onconetix, Inc.、知临集团、Eyenovia, Inc.较为活跃,换手率分别为1968.19%、1098.83%、243.06%,振幅较大的相关个股有Onconetix, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、知临集团,振幅分别为265.45%、217.20%、119.56%。Iteos Therapeutics, Inc.公司简介:ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231233632a2109896&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231233632a2109896&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ITOS","LENZ"],"gpt_icon":0},{"id":"2483640928","title":"Iteos Therapeutics, Inc.2024财年第三财季实现净利润-45.36百万美元,同比减少40.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483640928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483640928?lang=zh_cn&edition=full","pubTime":"2024-11-14 08:02","pubTimestamp":1731542537,"startTime":"0","endTime":"0","summary":"11月14日,Iteos Therapeutics, Inc.公布财报,公告显示公司2024财年第三财季净利润为-45.36百万美元,同比减少40.69%;其中营业收入为0.00美元,每股基本收益为-1.05美元。从资产负债表来看,Iteos Therapeutics, Inc.总负债91.39百万美元,其中短期债务1.35百万美元,资产负债比为0.08,流动比率为0.15。机构评级:截至2024年11月14日,当前有5家机构对Iteos Therapeutics, Inc.目标价做出预测,其中目标均价为32.00美元,其中最低目标价为22.00美元,最高目标价为46.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114080224a2355971&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114080224a2355971&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ITOS"],"gpt_icon":0},{"id":"2480832108","title":"Iteos Therapeutics, Inc.盘中异动 快速上涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480832108","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480832108?lang=zh_cn&edition=full","pubTime":"2024-11-02 00:59","pubTimestamp":1730480372,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日00时59分,Iteos Therapeutics, Inc.股票出现波动,股价急速拉升5.33%。截至发稿,该股报8.90美元/股,成交量59.633万股,换手率1.63%,振幅5.21%。Iteos Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.56%。其相关个股中,Revolution Medicines Inc C/Wts 17/12/2026 、Athira Pharma, Inc.、Theriva Biologics, Inc.涨幅较大,Theriva Biologics, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.较为活跃,换手率分别为3504.02%、890.00%、859.16%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Tc Biopharm Plc C/Wts 10/02/2028 、Immatics N V C/Wts 01/07/2025 ,振幅分别为122.67%、96.49%、60.77%。Iteos Therapeutics, Inc.公司简介:ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102005932a20a4e74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102005932a20a4e74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ITOS"],"gpt_icon":0},{"id":"2478932530","title":"Iteos Therapeutics, Inc.盘中异动 股价大涨5.12%报9.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478932530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478932530?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:26","pubTimestamp":1729866368,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日22时26分,Iteos Therapeutics, Inc.股票出现波动,股价快速拉升5.12%。截至发稿,该股报9.04美元/股,成交量7.5416万股,换手率0.21%,振幅4.77%。Iteos Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.92%。其相关个股中,Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Elevai Labs, Inc.涨幅较大,180 Life Sciences Corp.、Elevai Labs, Inc.、Tc Biopharm Plc较为活跃,换手率分别为720.21%、655.38%、158.47%,振幅较大的相关个股有Qualigen Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Elevai Labs, Inc.,振幅分别为91.58%、77.79%、69.41%。Iteos Therapeutics, Inc.公司简介:ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025222609a1eaa9f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025222609a1eaa9f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ITOS","BK4139","LENZ"],"gpt_icon":0},{"id":"2477986739","title":"Iteos Therapeutics, Inc.盘中异动 急速下跌5.09%报8.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477986739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477986739?lang=zh_cn&edition=full","pubTime":"2024-10-21 23:17","pubTimestamp":1729523825,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日23时17分,Iteos Therapeutics, Inc.股票出现异动,股价快速跳水5.09%。截至发稿,该股报8.95美元/股,成交量23.3408万股,换手率0.64%,振幅4.24%。Iteos Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.87%。其相关个股中,Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.涨幅较大,Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃,换手率分别为5703.11%、3001.05%、1290.23%,振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为369.73%、157.02%、148.15%。Iteos Therapeutics, Inc.公司简介:ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021231705a1e24f5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021231705a1e24f5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ITOS","BK4139","LENZ"],"gpt_icon":0},{"id":"2469416963","title":"Iteos Therapeutics, Inc.盘中异动 临近午盘快速下挫5.33%报10.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469416963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469416963?lang=zh_cn&edition=full","pubTime":"2024-09-24 23:36","pubTimestamp":1727192211,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日23时36分,Iteos Therapeutics, Inc.股票出现异动,股价急速下跌5.33%。截至发稿,该股报10.04美元/股,成交量22.2285万股,换手率0.61%,振幅4.53%。Iteos Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.41%。其相关个股中,Seelos Therapeutics, Inc.、Wave Life Sciences Ltd.、Capricor Therapeutics, Inc.涨幅较大,Seelos Therapeutics, Inc.、Silexion Therapeutics Corp、Onconetix, Inc.较为活跃,换手率分别为3935.01%、181.32%、127.21%,振幅较大的相关个股有Seelos Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Onconetix, Inc.,振幅分别为101.84%、58.52%、45.08%。Iteos Therapeutics, Inc.公司简介:ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092423365298e38b00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092423365298e38b00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ITOS","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.iteostherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0805},{"period":"1month","weight":0.0839},{"period":"3month","weight":-0.0854},{"period":"6month","weight":-0.1893},{"period":"1year","weight":-0.3646},{"period":"ytd","weight":-0.1081}],"compareEarnings":[{"period":"1week","weight":0.0513},{"period":"1month","weight":-0.0024},{"period":"3month","weight":-0.0789},{"period":"6month","weight":-0.0252},{"period":"1year","weight":0.0868},{"period":"ytd","weight":-0.0542}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"iTeos Therapeutics, Inc.根据特拉华州法律于2019年10月4日成立。该公司是临床阶段的生物制药公司,率先发现和开发了面向患者的新一代高度分化的免疫肿瘤疗法。该公司利用他们对肿瘤微环境和免疫抑制途径的深刻理解来设计新的候选药物,目的是提高肿瘤治疗的临床疗效。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.061341},{"month":2,"riseRate":0.4,"avgChangeRate":0.034522},{"month":3,"riseRate":0.2,"avgChangeRate":-0.084583},{"month":4,"riseRate":0.4,"avgChangeRate":-0.107686},{"month":5,"riseRate":0.5,"avgChangeRate":0.068217},{"month":6,"riseRate":0.5,"avgChangeRate":0.031423},{"month":7,"riseRate":0.75,"avgChangeRate":0.092866},{"month":8,"riseRate":0.4,"avgChangeRate":0.075236},{"month":9,"riseRate":0,"avgChangeRate":-0.164906},{"month":10,"riseRate":0.2,"avgChangeRate":-0.063472},{"month":11,"riseRate":0.8,"avgChangeRate":0.094564},{"month":12,"riseRate":0.6,"avgChangeRate":0.123748}],"exchange":"NASDAQ","name":"iTeos Therapeutics","nameEN":"iTeos Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"iTeos Therapeutics(ITOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供iTeos Therapeutics(ITOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"iTeos Therapeutics,ITOS,iTeos Therapeutics股票,iTeos Therapeutics股票老虎,iTeos Therapeutics股票老虎国际,iTeos Therapeutics行情,iTeos Therapeutics股票行情,iTeos Therapeutics股价,iTeos Therapeutics股市,iTeos Therapeutics股票价格,iTeos Therapeutics股票交易,iTeos Therapeutics股票购买,iTeos Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"iTeos Therapeutics(ITOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供iTeos Therapeutics(ITOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}